Skip to main navigation Skip to search Skip to main content

A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy

  • Tetsuya Yokosuka
  • , Toshiko Kobayashi
  • , Tatsuji Enomoto
  • , Atsuya Takeda

Research output: Contribution to journal › Article › peer-review

Abstract

An 80-year-old man with no complaint was referred to our department because of high serum CEA level. He was diagnosed as non-small cell lung cancer (adenocarcinoma) of the left lower lobe (c-T2aN0M0, stage IB), and therefore the left lower lobectomy with lymph node dissection was performed. Pathological staging was p-T2aN1 (#10) M0, stage IIA, and EGFR mutation was negative. Adjuvant chemotherapy with UFT was started, but multiple hilar and mediastinal lymph nodes metastases soon appeared. Carboplatin (CBDCA)+paclitaxel (PTX), erlotinib, and docetaxel (DOC) were attempted after that, but the lymph nodes increased in size and the CEA level was up to 159.8 ng/mL. At about the same time, brain and pulmonary metastases were recognized. After radiation for the chest lymph nodes and stereotactic radiosurgery (SRS) for the brain metastasis, oral S-1 monotherapy was introduced. Soon after, the lymph nodes shrinked and the CEA level decreased. Also, the pulmonary metastasis disappeared. Although a right supraclavicular lymph node metastasis was resected during the clinical course, the S-1 monotherapy has been continued with no serious adverse event. He is well (PS 0) without recurrent lesion, and his serum CEA level is within the normal limit.

Original languageEnglish
Pages (from-to)1201-1203
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume40
Issue number9
Publication statusPublished - 2013 Sept
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chemotherapy
  • Non-small cell lung cancer (NSCLC)
  • S-1

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy'. Together they form a unique fingerprint.

Cite this